News Releases News Releases HOME HOME



July 3, 2002

Taisho Launches Vicks Medicated Drop Business




On July 1, 2002, Taisho Pharmaceutical Co., Ltd. (President: Akira Uehara) started the business of Vicks Medicated Drops, a sore throat remedy in lozenge form, based on an agreement that Taisho has succeeded it from the Procter & Gamble Company (P&G, Headquarters: United States).

According to the contract concluded with P&G on May 14, Taisho Pharmaceutical acquired the right of using the brand "Vicks Medicated Drops" for indefinite period in Japan. For the time being, Taisho consigns manufacturing products to P&G.

The Vicks brand has a history of nearly 50 years at the top position in the Japanese OTC drug market. By adding the Vicks brand to its product lineup, Taisho expects to enhance its Self-Medication business further. Taisho has set a fiscal 2002 sales target of ¥2.0 billion for the Vicks brand.

The current contract limits Taisho Pharmaceutical’s right to the Vicks brand to Japanese market. The rest of the one billion dollar Vicks business in other parts of the world remains with P&G.

The contract signed on May 14 also calls for Taisho Pharmaceutical to become the Japan sales agent for Vicks VapoRub, a mentholated rub-type cold remedy. The timing of the launch will be announced separately.


Product Overview
Name Vicks Medicated Drops
Effects This bactericidal sore throat remedy in lozenge form helps relieve throat pain, hoarseness, sore throat, and other symptoms associated with a sore throat.
Flavors Regular, Lemon, Orange, and Cherry
Packaging 20 lozenges (4 packs of 5 lozenges) per package
Suggested retail price ¥400/package (excluding sales tax)
History
1931: Launched in the United States as Cough Drop
1953: Introduced to Japan by HANKYU KYOEI BUSSAN CO., LTD.
1994: Name changed to Vicks Medicated Drops